EPISODE · Jun 15, 2022 · 29 MIN
Let's Talk Medtech: Kevin Sayer on Why all eyes are on Dexcom
from Let’s Talk Medtech
It's no secret that Dexcom is on the rise. From commercials during the Super Bowl, to blockbuster products on the horizon, the company is reaching a new height of popularity in the continuous glucose monitoring space. Kevin Sayer, Dexcom CEO, talks about the company's new position the space and all the hype surrounding the upcoming G7 CGM sensor. He also gives his thoughts on where CGM technology is headed in this incredible, can't miss conversation.
NOW PLAYING
Let's Talk Medtech: Kevin Sayer on Why all eyes are on Dexcom
No transcript for this episode yet
Similar Episodes
Feb 8, 2026 ·4m
Jan 30, 2026 ·6m
Dec 15, 2025 ·2m
Nov 30, 2025 ·5m
Oct 26, 2025 ·14m
Oct 26, 2025 ·61m